| Financial Year |
March 31 2023 |
| Monetary Funds |
1,474,452,291.39 |
| Held-for-trading Financial Assets |
110,410,095.04 |
| Notes Receivable |
731,753.18 |
| Accounts Receivable |
222,486,831.35 |
| Advances to Suppliers |
8,343,115.97 |
| Other Receivables |
2,883,113.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
440,128,475.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,588,446.05 |
| Total Current Assets |
2,269,024,121.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
45,695,163.02 |
| Fixed Assetes |
396,969,959.70 |
| Under-construction Projects |
975,748.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
51,941,347.60 |
| R&D expenses |
-- |
| Goodwill |
2,722,859.05 |
| Long-Term Deferred and Prepaid Expenses |
5,926,539.48 |
| Deferred Income Tax Assets |
25,901,789.29 |
| Other Non-Current Assets |
244,898.00 |
| Sub-Total of Non-Current Assets |
560,614,663.63 |
| Total Assets |
2,829,638,785.32 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
211,497,319.70 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
31,296,421.03 |
| Taxes Payable |
32,144,234.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,799,217.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,084,867.15 |
| Other Current Liabilities |
11,756,877.14 |
| Sub-Total of Current Liabilities |
323,910,437.28 |
| Long-term Loans |
4,444,907.50 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,163,559.82 |
| Deferred Income Tax Liabilities |
27,425,638.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
58,964,824.42 |
| Total Liabilities |
382,875,261.70 |
| Paid-In Capital(Or Share Stock) |
889,107,000.00 |
| Capital Surplus |
469,459,333.24 |
| Surplus Reserve |
139,880,559.09 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
868,974,574.34 |
| Minority Stockholder's Interest |
72,597,147.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,374,166,375.76 |
| Owner's Equity（Stockholder's Equity） |
2,446,763,523.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,829,638,785.32 |
